Molecular Partners Publishes Invitation to Annual General
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a clinical-stage...
Source: globenewswire.com
Page 5 - Nasdaq Moln News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Moln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Moln Today - Breaking & Trending Today
Molecular Partners Reports Corporate Highlights From Q4
Research & Development Highlights: In January of 2022, announced positive topline results from Phase 2 EMPATHY clinical trial of ensovibep for the...
Source: globenewswire.com
Molecular Partners to Present at Upcoming Healthcare
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a...
Source: globenewswire.com
Molecular Partners Finalizes License Agreement with
Agreement grants global rights of ensovibep to Novartis, who will lead further development and commercialization of the programFinancial terms include...
Source: globenewswire.com
Molecular Partners and Novartis Report Positive Topline
Topline results from the randomized, placebo-controlled EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of...
Source: globenewswire.com